跳至主要内容
临床试验/ACTRN12622001551785
ACTRN12622001551785尚未招募2 期

Effect of treatment with fludrocortisone on the incidence of hyponatremia in patients with aneurysmal sub arachnoid haemorrhage: a pilot study

Metro North Hospital and Health Service0 个研究点目标入组 40 人开始时间: 2022年12月15日最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Prevention
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.Age 18 years or older
  • 2.Diagnosed with aneurysmal subarachnoid haemorrhage (aSAH) from an aneurysm confirmed on computed tomography angiography (CTA) or digital subtraction angiography (DSA) of the intra-cranial arteries
  • 3.Admitted to an Intensive Care or High Dependency Unit
  • 4.Hospital admission for aneurysmal subarachnoid haemorrhage within 96 hours

排除标准

  • 1.Unable to receive enteral medications
  • 2.Pre-existing glucocorticoid or mineralocorticoid treatment (excluding inhaled)
  • 3.Previous allergic reaction to fludrocortisone
  • 4.Hospital admission for aSAH greater than 96 hours ago
  • 5.History of cardiac, hepatic or renal failure
  • 6.Hypernatraemia (Na>145mol/L) on the most recent blood sample at the time of screening.
  • 7.Death deemed imminent or inevitable
  • 8.Pregnancy (confirmed or suspected)
  • 9.Documented systemic fungal infection
  • 10.Previous enrolment in the trial

研究者

相似试验